DSE : ORIONINFU

Orion Infusion Limited

Biological Products, Except Diagnostic Substances · Bangladesh

Last price 228.7 BDT (At close: Oct 28, 2026) · Market cap 4.66B

Latest research: Orion Infusion financial analysis: ten flat years, 20% FY2025 sales fall and a 131x P/E (Oct 2026) · Orion Infusion: FY2025 sales fell 20% to BDT 665m and 9M FY2026 sales fell a further 3.5%, while the shares trade at 131x trailing earnings

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Orion Infusion Limited manufactures and sells large volume parenteral and other lifesaving injectable products in Bangladesh. The company offers I.V. rehydration, electrolyte, and acidosis solutions; ranitidine I.V. infusion; anti-microbial products; metronidazole I.V; pure steam generated fluids; and amino acids solution. It also provides sterile and nonpyrogenic solution, such as Dextrolac, Dianak, Hartman, Manisol, Plasmasol, and Proliv; hypertonic solution, including Dextrosal, Electrodex-10, Fructose – 10, Orlev, Ortac; Dextropac, an isoto...

Technical report: trend, RSI, support and resistance, charts

Reports